Cargando…
All-Cause Health Care Utilization and Costs Associated with Newly Diagnosed Multiple Sclerosis in the United States
BACKGROUND: Multiple sclerosis (MS) is a costly and crippling neurologic disease. Approximately 250,000 to 400,000 persons in the United States are currently diagnosed with MS. Most individuals experience their first symptoms between the ages of 20 and 40 years; therefore, this disease may have subs...
Autores principales: | Asche, Carl V., Singer, Mendel E., Jhaveri, Mehul, Chung, Hsingwen, Miller, Aaron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437448/ https://www.ncbi.nlm.nih.gov/pubmed/21067256 http://dx.doi.org/10.18553/jmcp.2010.16.9.703 |
Ejemplares similares
-
Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States
por: Kern, David M., et al.
Publicado: (2020) -
Economic Evaluation of Healthcare Resource Utilization and Costs for Newly Diagnosed Dementia-Related Psychosis
por: Rashid, Nazia, et al.
Publicado: (2022) -
Newly Diagnosed Idiopathic Liver Abscess: Colonoscopy Required!
por: Makkar, Priyanka, et al.
Publicado: (2017) -
Vaccination frequency in people newly diagnosed with multiple sclerosis
por: Darvishi, Sonia, et al.
Publicado: (2023) -
Prognostic Usefulness of Motor Unit Number Index (MUNIX) in Patients Newly Diagnosed with Amyotrophic Lateral Sclerosis
por: Risi, Barbara, et al.
Publicado: (2023)